Find more information about Teva in your location, or contact a local representative on our local sites
North America
International Markets
North America
Toggle North America
International Markets
Toggle International Markets
Europe
Toggle Europe
Teva Innovative Medicine & Biosimilar Pipeline
By development stage – as of November 1, 2024
Technology Platforms:
Download a PDF version of Teva Innovative Medicine and Biosimilar Pipeline
Teva innovative medicine and biosimilar pipeline by development stage, excluding country / regional launches of products submitted or under review in new markets.
Pipeline is current as of November 1, 2024.
-
Back to contents.
In collaboration with MODAG.
-
Back to contents.
In collaboration with Sanofi.
-
Back to contents.
In collaboration with Alvotech for the U.S. market.
-
Back to contents.
In collaboration with Launch Therapeutics.
-
Back to contents.
In collaboration with mAbxience.
